Patient-reported outcomes and quality of life with sunitinib versus placebo for pancreatic neuroendocrine tumors: results from an international phase III trial.
Authors
Vinik, ABottomley, A
Korytowsky, B
Bang, Y
Raoul, J
Valle, Juan W
Metrakos, P
Hörsch, D
Mundayat, R
Reisman, A
Wang, Z
Chao, R
Raymond, E
Affiliation
Strelitz Diabetes Research Center and Neuroendocrine Unit, Eastern Virginia Medical School, Strelitz Diabetes Center, Norfolk, VA, USA.Issue Date
2016-12
Metadata
Show full item recordAbstract
The objective of this analysis was to compare patient-reported outcomes and health-related quality of life (HRQoL) in a pivotal phase III trial of sunitinib versus placebo in patients with progressive, well-differentiated pancreatic neuroendocrine tumors (NCT00428597).Citation
Patient-reported outcomes and quality of life with sunitinib versus placebo for pancreatic neuroendocrine tumors: results from an international phase III trial. 2016, 11 (6):815-824 Target OncolJournal
Targeted OncologyDOI
10.1007/s11523-016-0462-5PubMed ID
27924459Type
ArticleLanguage
enISSN
1776-260Xae974a485f413a2113503eed53cd6c53
10.1007/s11523-016-0462-5
Scopus Count
Collections
Related articles
- Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.
- Authors: Raymond E, Dahan L, Raoul JL, Bang YJ, Borbath I, Lombard-Bohas C, Valle J, Metrakos P, Smith D, Vinik A, Chen JS, Hörsch D, Hammel P, Wiedenmann B, Van Cutsem E, Patyna S, Lu DR, Blanckmeister C, Chao R, Ruszniewski P
- Issue date: 2011 Feb 10
- Sunitinib: in advanced, well differentiated pancreatic neuroendocrine tumors.
- Authors: Deeks ED, Raymond E
- Issue date: 2011 Oct 1
- Sunitinib in pancreatic neuroendocrine tumors.
- Authors: Raymond E, Hammel P, Dreyer C, Maatescu C, Hentic O, Ruszniewski P, Faivre S
- Issue date: 2012 Jun
- Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study.
- Authors: Faivre S, Niccoli P, Castellano D, Valle JW, Hammel P, Raoul JL, Vinik A, Van Cutsem E, Bang YJ, Lee SH, Borbath I, Lombard-Bohas C, Metrakos P, Smith D, Chen JS, Ruszniewski P, Seitz JF, Patyna S, Lu DR, Ishak KJ, Raymond E
- Issue date: 2017 Feb 1
- Activity of sunitinib in patients with advanced neuroendocrine tumors.
- Authors: Kulke MH, Lenz HJ, Meropol NJ, Posey J, Ryan DP, Picus J, Bergsland E, Stuart K, Tye L, Huang X, Li JZ, Baum CM, Fuchs CS
- Issue date: 2008 Jul 10